Product Information

TETRABENAZINE 12.5 MG TABLET is a generic product labeled by Bionpharma Inc., priced at $0.6425 per EA under NDC 69452011721. Its NADAC has been published 196 times since Feb 22, 2023.

FDA first approved this application on Dec 18, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TETRABENAZINE 12.5 MG TABLET

TETRABENAZINE
$0.6425per EA

Strength

12.5 mg/1

Manufacturer

Bionpharma Inc.

NDC

69452011721

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

TETRABENAZINE

Approval Type

Generic (ANDA)

FDA Application

ANDA208826

FDA Approved

12/18/2017

TE Code

AB

On Market Since

1/15/2018

Pharmacological Classes

Vesicular Monoamine Transporter 2 Inhibitor
Vesicular Monoamine Transporter 2 Inhibitors

Price Statistics

The NADAC for TETRABENAZINE 12.5 MG TABLET has been published 196 times since Feb 22, 2023, and over the history we have for it it has declined 75.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6425 per EA
All-time high$3.2465 (Dec 13, 2023)
All-time low$0.6425 (Nov 18, 2026)
52-week high$0.8066
52-week low$0.6425
Median price$1.3077
Average price$1.6155
Largest weekly change-63.3% (Dec 20, 2023)
Weeks tracked196
Tracking sinceFeb 22, 2023

Price History

1W

-4.7%

1M

-8.5%

3M

-15.5%

6M

-20.1%

1Y

-17.2%

3Y

-80.2%

5Y

N/A

All

-75.2%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TETRABENAZINE 12.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TETRABENAZINE 12.5 MG TABLET, manufactured by Bionpharma Inc., is $0.6425 per EA (NDC 69452011721), effective Nov 18, 2026.

How has the price of TETRABENAZINE 12.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for TETRABENAZINE 12.5 MG TABLET has declined 75.2%. It has been tracked across 196 weekly CMS publications since Feb 22, 2023.

What are the highest and lowest recorded NADAC prices for TETRABENAZINE 12.5 MG TABLET?

Since Feb 22, 2023, the NADAC for TETRABENAZINE 12.5 MG TABLET has ranged from a low of $0.6425 (Nov 18, 2026) to a high of $3.2465 (Dec 13, 2023), with a median of $1.3077 per EA.

Are there cheaper alternatives to TETRABENAZINE 12.5 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TETRABENAZINE 12.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures TETRABENAZINE 12.5 MG TABLET?

TETRABENAZINE 12.5 MG TABLET (NDC 69452011721) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.